The intracellular distribution of inositol polyphosphates in HL60 promyeloid cells.

by Stuart, J A, Anderson, K L, French, P J, Kirk, C J, Michell, R H
Published 1994

A mouse model for the cystic fibrosis delta F508 mutation.

by van Doorninck, J H, French, P J, Verbeek, E, Peters, R H, Morreau, H, Bijman, J, Scholte, B J
Published 1995

Comparison of the levels of inositol metabolites in transformed haemopoietic cells and their normal counterparts.

by Bunce, C M, French, P J, Allen, P, Mountford, J C, Moor, B, Greaves, M F, Michell, R H, Brown, G
Published 1993

Inositol 1,2,3-trisphosphate and inositol 1,2- and/or 2,3-bisphosphate are normal constituents of mammalian cells.

by Barker, C J, French, P J, Moore, A J, Nilsson, T, Berggren, P O, Bunce, C M, Kirk, C J, Michell, R H
Published 1995

P01.066 Patients with EGFR amplification but without EGFRvIII expression have improved benefit compared to those with EGFRvIII expression in samples of the INTELLANCE 2/EORTC 1410...

by French, P J, Kros, J, de Heer, I, Ansell, P, Looman, J, Bain, E, Morfouace, M, Gorlia, T, Golfinopoulos, V, van den Bent, M
Published in Neuro Oncol (2018)

Gene expression profiles of gliomas in formalin-fixed paraffin-embedded material

by Gravendeel, L A M, de Rooi, J J, Eilers, P H C, van den Bent, M J, Sillevis Smitt, P A E, French, P J
Published 2012

P01.12 Stability of actionable mutations in primary and recurrent glioblastomas

by French, P. J., Taphoorn, M., Weyerbrock, A., Sanson, M., Hoeben, A., Lukavoca, S., Lombardi, G., Hanse, M., Watts, C., Golfinopoulos, V., McDermott, U., Robe, P.
Published in Neuro Oncol (2017)

OS5.3 Stability of actionable mutations in primary and recurrent glioblastomas

by Draaisma, K., Taphoorn, M., Weyerbrock, A., Sanson, M., Gorlia, T., Golfinopoulos, V., Kros, J. M., Robe, P. A., van den Bent, M. M. J., French, P. J.
Published in Neuro Oncol (2016)

A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.

by French, P J, van Doorninck, J H, Peters, R H, Verbeek, E, Ameen, N A, Marino, C R, de Jonge, H R, Bijman, J, Scholte, B J
Published 1996

OS10.1 Survival analysis of IDH wildtype astrocytomas with molecular features of glioblastoma, WHO grade IV

by Tesileanu, C M S, Koekkoek, J A F, Dirven, L, Dubbink, H J, Kros, J M, van Duinen, S G, Smits, M, French, P J, Taphoorn, M J B, van den Bent, M J
Published in Neuro Oncol (2019)

OS5.6 Initial treatment strategy for presumed low-grade glioma: a preoperative perspective

by Wijnenga, M. M. J., Mattni, T., French, P. J., Rutten, G. J., Leenstra, S., Kloet, F., Taphoorn, M. J. B., van den Bent, M. J., van Veelen, M. L. C., Vincent, A. J. P. E.
Published in Neuro Oncol (2016)

P11.47 Generation, characterisation and drug screening of patient-derivedIDH1-mutated glioma cell lines

by Verheul, C, Kers, T V, Van Der Ploeg, A, Van Der Kaaij, M, Aghababazadeh, M, De Wit, M, Hoogstrate, Y, Struys, E, Dirven, C M F, Leenstra, S, French, P J, Lamfers, M L M
Published in Neuro Oncol (2019)

P04.11 Voxelwise correlation between vascular MRI parameters obtained with ASL and DSC is decreased in IDH-wt non-enhancing glioma

by Warnert, E A H, Incekara, F, Vincent, A J P E, Schouten, J W, van den Bent, M J, French, P J, Dubbink, H J, Kros, J M, Hernandez-Tamames, J A, Smits, M
Published in Neuro Oncol (2019)

PL3.3 Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/...

by van den Bent, M J, Erridge, S, Vogelbaum, M A, Nowak, A K, Sanson, M, Brandes, A A, Wick, W, Clement, P M, Baurain, J F, Mason, W, Wheeler, H, Weller, M, Aldape, K, Wesseling, P, Kros, J M, Tesileanu, C M S, Golfinopoulos, V, Gorlia, T, Baumert, B G, French, P J
Published in Neuro Oncol (2019)